Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Ipamorelin versus sermorelin

Sermorelin is a growth hormone releasing hormone analog rather than a ghrelin mimetic like ipamorelin. It works through a different receptor system to achieve similar ends. The side effect profile is comparably clean to ipamorelin, with low rates of concerning

This comparison does not assign a generated winner or score.

  • Sermorelin is a growth hormone releasing hormone analog rather than a ghrelin mimetic like ipamorelin. It works through a different receptor system to achieve similar ends. The side effect profile is comparably clean to ipamorelin, with low rates of concerning reactions.
  • The main difference is potency. Sermorelin tends to produce smaller GH releases than ipamorelin. Some researchers find it insufficient for their goals. Others appreciate the gentler approach, particularly as an introduction to growth hormone optimization.
  • Combining ipamorelin with CJC-1295, which is functionally similar to sermorelin, is a common strategy. This combination leverages the strengths of both pathways while keeping side effects manageable. The ipamorelin versus CJC-1295 comparison page provides detailed analysis of these options.
More references

Related material

Comparison

Ipamorelin versus GHRP-2

GHRP-2 was developed as an improvement over GHRP-6, and it is in some ways. The hunger effect is reduced compared to GHRP-6, though still present. GHRP-2 is more potent for growth…

View details →
Comparison

Ipamorelin versus GHRP-6

GHRP-6 is an older growth hormone secretagogue with a very different side effect profile. The most notorious difference is hunger. GHRP-6 causes intense, sometimes overwhelming hu…

View details →
Comparison

Ipamorelin versus MK-677

MK-677, also known as ibutamoren, is often compared to ipamorelin though it is not technically a peptide. It is an oral growth hormone secretagogue, which makes it convenient, but…

View details →